Wockhard board to mull fund raising on 6 Jan

Image
Capital Market
Last Updated : Jan 04 2022 | 9:52 AM IST

Wockhardt on Monday announced that the company's board will meet on Thursday, 6 January 2022 to consider and approve various fund-raising options.

The drug maker further said that details of the proposal shall be intimated in the outcome of the meeting.

Wockhardt is a research based global pharmaceutical and biotech company. The company reported a consolidated net profit of Rs 34 crore in Q2 FY22 as against a net profit of Rs 4 crore in Q2 FY21. Sales increased by 21% YoY to Rs 862 crore during the quarter.

Shares of Wockhardt were trading 2.13% higher at Rs 421.20 on BSE.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Jan 04 2022 | 9:45 AM IST

Next Story